Levofloxacino oral frente a ceftriaxona y a amoxicilina/ácido clavulánico intravenosos en el tratamiento de la neumonía adquirida en la comunidad que requiere hospitalización
Levofloxacin versus ceftriaxone and intravenous amoxicillin/clavulanate in the treatment of community-acquired pneumonia that require hospitalization
Verónica Kalbermatter, Daniel Bagilet
, Mario Diab, Eduardo Javkin
Autor para correspondencia
Servicio de ClÍnica Médica. Sanatorio Delta. Rosario. Argentina.
Leído
8709
Vecesse ha leído el artículo
2938
Total PDF
5771
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 17 | 17 |
| 2025 11 | 0 | 43 | 43 |
| 2025 10 | 0 | 46 | 46 |
| 2025 9 | 0 | 62 | 62 |
| 2025 8 | 0 | 52 | 52 |
| 2025 7 | 0 | 43 | 43 |
| 2025 6 | 1 | 36 | 37 |
| 2025 5 | 0 | 41 | 41 |
| 2025 4 | 0 | 64 | 64 |
| 2025 3 | 0 | 48 | 48 |
| 2025 2 | 0 | 53 | 53 |
| 2025 1 | 0 | 53 | 53 |
| 2024 12 | 0 | 66 | 66 |
| 2024 11 | 1 | 50 | 51 |
| 2024 10 | 0 | 31 | 31 |
| 2024 9 | 1 | 52 | 53 |
| 2024 8 | 1 | 46 | 47 |
| 2024 7 | 2 | 26 | 28 |
| 2024 6 | 0 | 40 | 40 |
| 2024 5 | 2 | 26 | 28 |
| 2024 4 | 3 | 39 | 42 |
| 2024 3 | 2 | 29 | 31 |
| 2024 2 | 0 | 59 | 59 |
| 2024 1 | 0 | 49 | 49 |
| 2023 12 | 1 | 52 | 53 |
| 2023 11 | 1 | 52 | 53 |
| 2023 10 | 0 | 68 | 68 |
| 2023 9 | 0 | 36 | 36 |
| 2023 8 | 0 | 17 | 17 |
| 2023 7 | 0 | 48 | 48 |
| 2023 6 | 2 | 37 | 39 |
| 2023 5 | 1 | 37 | 38 |
| 2023 4 | 1 | 24 | 25 |
| 2023 3 | 264 | 42 | 306 |
| 2023 2 | 0 | 23 | 23 |
| 2022 1 | 0 | 24 | 24 |
| 2022 12 | 0 | 27 | 27 |
| 2022 11 | 3 | 32 | 35 |
| 2022 10 | 1 | 31 | 32 |
| 2022 9 | 2 | 31 | 33 |
| 2022 8 | 1 | 56 | 57 |
| 2022 7 | 0 | 59 | 59 |
| 2022 6 | 0 | 40 | 40 |
| 2022 5 | 5 | 22 | 27 |
| 2022 4 | 1 | 18 | 19 |
| 2022 3 | 0 | 36 | 36 |
| 2022 2 | 3 | 30 | 33 |
| 2021 1 | 0 | 48 | 48 |
| 2021 12 | 0 | 35 | 35 |
| 2021 11 | 0 | 36 | 36 |
| 2021 10 | 0 | 41 | 41 |
| 2021 9 | 0 | 38 | 38 |
| 2021 8 | 0 | 33 | 33 |
| 2021 7 | 7 | 28 | 35 |
| 2021 6 | 0 | 31 | 31 |
| 2021 5 | 0 | 23 | 23 |
| 2021 4 | 2 | 89 | 91 |
| 2021 3 | 0 | 38 | 38 |
| 2021 2 | 1 | 39 | 40 |
| 2020 1 | 1 | 34 | 35 |
| 2020 12 | 1 | 32 | 33 |
| 2020 11 | 1 | 25 | 26 |
| 2020 10 | 0 | 16 | 16 |
| 2020 9 | 1 | 13 | 14 |
| 2020 8 | 0 | 23 | 23 |
| 2020 7 | 0 | 6 | 6 |
| 2020 6 | 0 | 9 | 9 |
| 2020 5 | 1 | 12 | 13 |
| 2020 4 | 1 | 9 | 10 |
| 2020 3 | 0 | 9 | 9 |
| 2020 2 | 1 | 5 | 6 |
| 2020 1 | 0 | 7 | 7 |
| 2019 12 | 0 | 6 | 6 |
| 2019 11 | 0 | 6 | 6 |
| 2019 10 | 1 | 9 | 10 |
| 2019 9 | 0 | 6 | 6 |
| 2019 7 | 2 | 7 | 9 |
| 2019 6 | 0 | 6 | 6 |
| 2019 5 | 1 | 22 | 23 |
| 2019 4 | 1 | 2 | 3 |
| 2019 3 | 1 | 0 | 1 |
| 2018 6 | 0 | 1 | 1 |
| 2018 4 | 0 | 1 | 1 |
| 2018 3 | 0 | 1 | 1 |
| 2017 10 | 35 | 46 | 81 |
| 2017 9 | 58 | 50 | 108 |
| 2017 8 | 60 | 18 | 78 |
| 2017 7 | 84 | 23 | 107 |
| 2017 6 | 71 | 16 | 87 |
| 2017 5 | 45 | 9 | 54 |
| 2017 4 | 61 | 4 | 65 |
| 2017 3 | 77 | 19 | 96 |
| 2017 2 | 50 | 8 | 58 |
| 2016 1 | 75 | 6 | 81 |
| 2016 12 | 125 | 13 | 138 |
| 2016 11 | 123 | 10 | 133 |
| 2016 10 | 137 | 22 | 159 |
| 2016 9 | 55 | 18 | 73 |
| 2016 8 | 24 | 10 | 34 |
| 2016 7 | 66 | 1 | 67 |
| 2016 6 | 101 | 1 | 102 |
| 2016 5 | 131 | 0 | 131 |
| 2016 4 | 124 | 2 | 126 |
| 2016 3 | 127 | 0 | 127 |
| 2016 2 | 96 | 2 | 98 |
| 2015 1 | 58 | 0 | 58 |
| 2015 12 | 72 | 1 | 73 |
| 2015 11 | 71 | 0 | 71 |
| 2015 10 | 85 | 0 | 85 |
| 2015 9 | 61 | 0 | 61 |
| 2015 8 | 72 | 0 | 72 |
| 2015 7 | 59 | 0 | 59 |
| 2015 6 | 40 | 0 | 40 |
| 2015 5 | 91 | 0 | 91 |
| 2015 4 | 59 | 0 | 59 |
| 2015 3 | 42 | 0 | 42 |
| 2015 2 | 11 | 0 | 11 |
| 2015 1 | 20 | 0 | 20 |
| 2014 12 | 19 | 0 | 19 |
| 2014 11 | 12 | 0 | 12 |
| 2014 10 | 14 | 0 | 14 |
| 2014 9 | 15 | 0 | 15 |
| 2014 8 | 11 | 0 | 11 |
| 2014 7 | 11 | 0 | 11 |
| 2014 6 | 14 | 0 | 14 |
| 2014 5 | 7 | 0 | 7 |
| 2014 4 | 10 | 0 | 10 |
| 2014 3 | 10 | 0 | 10 |
| 2014 2 | 8 | 0 | 8 |
| 2014 1 | 7 | 0 | 7 |
| 2013 12 | 6 | 0 | 6 |
| 2013 11 | 22 | 0 | 22 |
| 2013 10 | 25 | 0 | 25 |
| 2013 9 | 25 | 0 | 25 |
| 2013 8 | 11 | 0 | 11 |
| 2013 7 | 1 | 0 | 1 |
| 2000 11 | 2755 | 0 | 2755 |
Mostrar todo
